1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Oligometastatic Esophageal Adenocarcinoma: new trials by email Literature Review of Oligometastatic Esophageal Adenocarcinoma trials Research Report on Oligometastatic Esophageal Adenocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body Capecitabine, Fluorouracil, Leucovorin - Clinical Stage IV Esophageal Adenocarcinoma AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8 | Phase 3 | Active not recruiting | ECOG-ACRIN Cancer Research Group | 314 | 2020-05-26 | 2026-10-19 |
Adenocarcinoma Of Esophagus (1)
Capecitabine (1) · Fluorouracil (1) · Leucovorin (1) · Oxaliplatin (1) · Radiation (1) · Radiotherapy (1) · dehydroftorafur (1)
ECOG-ACRIN Cancer Research Group (1)
United States (1)
Nataliya V Uboha (1)
U10CA180820 (1)